Hyperbarics and Long-Haul Covid
Research studies and clinical trials are being conducted around the globe to assess the efficacy of hyperbaric oxygen therapy in helping long-haul COVID sufferers heal in a safe atmosphere of oxygen.
A recent study evaluated hyperbaric oxygen therapy for long-haul COVID treatment and found a statistically significant improvement in the patients’ executive function, attention, information processing, and more following 10 sessions.
There are also promising ongoing clinical trials studying the efficacy of HBOT for long-haul COVID syndrome in general and specific post-COVID conditions like pulmonary sequelae.
There are a wide range of patient symptoms, but the ones we’ve seen being treated most frequently include:
One of the most common symptoms, present in up to 65% of long-haul Covid patients.
This can be particularly severe, preventing people from performing their usual work and activities
Similarities to Chronic Fatigue Syndrome
HBOT has been shown to be safe and effective in treating Chronic Fatigue Syndrome
Low oxygen saturation due to lung damage from COVID Pneumonia
Reliance on supplemental oxygen at home
Most of the patients have found relief with as little as five hyperbaric oxygen treatments while others needed 10-40 based on chronicity of their condition. About halfway through treatment, many patients return to their pre-COVID lifestyle and most have an almost comparable recovery after the protocol has been completed.
The mechanism of long-haul COVID is still uncertain. One possible hypothesis is that the wide variety of changes that characterize long-haul COVID are a result of prolonged tissue hypoxia. This is frequently the common denominator for many diseases that are responsive to HBOT.
Want to learn more about hyperbaric oxygen therapy for post COVID recovery?